Pharming Group (PHAR) News Today $9.10 +0.16 (+1.79%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Pharming Group (NASDAQ:PHAR) Shares Gap Up - Still a Buy?Pharming Group (NASDAQ:PHAR) Shares Gap Up - Time to Buy?December 19 at 1:21 PM | marketbeat.comHC Wainwright Reiterates Buy Rating for Pharming Group (NASDAQ:PHAR)December 19 at 4:13 AM | americanbankingnews.comPharming Group (NASDAQ:PHAR) Shares Gap Down - Here's WhyPharming Group (NASDAQ:PHAR) Shares Gap Down - Should You Sell?December 18 at 1:09 PM | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Pharming Group (NASDAQ:PHAR)HC Wainwright reaffirmed a "buy" rating and set a $37.00 price objective on shares of Pharming Group in a research report on Tuesday.December 17, 2024 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: Viridian Therapeutics (VRDN), Pharming Group (PHAR)December 17, 2024 | markets.businessinsider.comPharming Group offers to buy Sweden's Abliva for SEK 0.45/shrDecember 16, 2024 | seekingalpha.comPharming Group Offers To Acquire Abliva For SEK 0.45/shr In CashDecember 16, 2024 | markets.businessinsider.comPharming announces public cash offer to the shareholders of Abliva ABDecember 15, 2024 | markets.businessinsider.comRBC Capital Remains a Buy on Pharming Group (PHGUF)December 13, 2024 | markets.businessinsider.comPharming announces positive topline data in pediatric clinical trial of leniolisibDecember 11, 2024 | markets.businessinsider.comEuropean Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder DrugDecember 11, 2024 | benzinga.comPharming Group (NASDAQ:PHAR) Given "Buy" Rating at HC WainwrightHC Wainwright restated a "buy" rating and set a $37.00 price objective on shares of Pharming Group in a report on Wednesday.December 11, 2024 | marketbeat.comPharming Group’s Pediatric Trial Yields Positive ResultsDecember 11, 2024 | tipranks.comPharming initiated with a Buy at JefferiesDecember 9, 2024 | markets.businessinsider.comJefferies Initiates Coverage of Pharming Group N.V. - Depositary Receipt () (PHAR) with Buy RecommendationDecember 9, 2024 | msn.comJefferies Initiates Coverage of Pharming Group N.V. - Depositary Receipt () (PHAR) with Buy RecommendationDecember 9, 2024 | msn.comCritical Insights From Pharming Analyst Ratings: What You Need To KnowDecember 9, 2024 | benzinga.comCritical Insights From Pharming Analyst Ratings: What You Need To KnowDecember 9, 2024 | benzinga.comJefferies Financial Group Initiates Coverage on Pharming Group (NASDAQ:PHAR)Jefferies Financial Group initiated coverage on Pharming Group in a report on Monday. They set a "buy" rating and a $14.00 price target on the stock.December 9, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Here's WhyPharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Here's What HappenedDecember 6, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Short Interest UpdatePharming Group (NASDAQ:PHAR - Get Free Report) saw a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 25,500 shares, an increase of 165.6% from the October 31st total of 9,600 shares. Based on an average trading volume of 6,600 shares, the days-to-cover ratio is currently 3.9 days.November 28, 2024 | marketbeat.comPharming Group And 2 Other Promising Penny Stocks To WatchNovember 26, 2024 | finance.yahoo.comPharming Group (NASDAQ:PHAR) Shares Gap Down - Here's What HappenedPharming Group (NASDAQ:PHAR) Shares Gap Down - Time to Sell?November 19, 2024 | marketbeat.comEncore Healthcare: Pharming the FutureNovember 11, 2024 | msn.comPharming Group N.V. (PHARM.AS)November 8, 2024 | finance.yahoo.comPharming Group to participate in November investor conferenceNovember 5, 2024 | finance.yahoo.comPharming price target lowered to EUR 1.60 from EUR 1.65 at RBC CapitalNovember 4, 2024 | markets.businessinsider.comPharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Should You Buy?Pharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - Time to Buy?November 4, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Down 4.5% - Here's What HappenedPharming Group (NASDAQ:PHAR) Trading Down 4.5% - What's Next?November 1, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) PT Lowered to $30.00Oppenheimer dropped their price target on shares of Pharming Group from $31.00 to $30.00 and set an "outperform" rating on the stock in a research report on Monday.October 28, 2024 | marketbeat.comHC Wainwright Weighs in on Pharming Group FY2027 EarningsPharming Group (NASDAQ:PHAR - Free Report) - Stock analysts at HC Wainwright dropped their FY2027 earnings per share estimates for Pharming Group in a research report issued on Thursday, October 24th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings per shareOctober 28, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Large Growth in Short InterestPharming Group (NASDAQ:PHAR - Get Free Report) was the target of a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 9,100 shares, an increase of 122.0% from the September 30th total of 4,100 shares. Based on an average daily volume of 7,500 shares, the short-interest ratio is presently 1.2 days.October 26, 2024 | marketbeat.comPharming Group (PHGUF) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...October 25, 2024 | finance.yahoo.comPositive Outlook for Pharming Group Amidst Growth Opportunities and Leadership TransitionOctober 25, 2024 | markets.businessinsider.comPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - Here's WhyPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - What's Next?October 25, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Given Buy Rating at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $37.00 price target on shares of Pharming Group in a research note on Thursday.October 24, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Down - Time to Sell?Pharming Group (NASDAQ:PHAR) Shares Gap Down - What's Next?October 24, 2024 | marketbeat.comPharming Group N.V. 2024 Q3 - Results - Earnings Call PresentationOctober 24, 2024 | seekingalpha.comPharming Group (NASDAQ:PHAR) Shares Up 4.3% - Here's WhyPharming Group (NASDAQ:PHAR) Shares Up 4.3% - Still a Buy?October 23, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up - What's Next?Pharming Group (NASDAQ:PHAR) Shares Gap Up - Still a Buy?October 22, 2024 | marketbeat.comPharming Group to Post FY2026 Earnings of $1.24 Per Share, HC Wainwright Forecasts (NASDAQ:PHAR)Pharming Group (NASDAQ:PHAR - Free Report) - Investment analysts at HC Wainwright cut their FY2026 earnings per share estimates for shares of Pharming Group in a report issued on Tuesday, October 15th. HC Wainwright analyst J. Pantginis now forecasts that the company will post earnings of $1.24 pOctober 17, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Pharming Group (PHAR) and MoonLake Immunotherapeutics (MLTX)October 16, 2024 | markets.businessinsider.comHC Wainwright Comments on Pharming Group's FY2025 Earnings (NASDAQ:PHAR)Pharming Group (NASDAQ:PHAR - Free Report) - Analysts at HC Wainwright cut their FY2025 earnings estimates for shares of Pharming Group in a research report issued on Tuesday, October 15th. HC Wainwright analyst J. Pantginis now expects that the company will earn $0.60 per share for the year, dowOctober 16, 2024 | marketbeat.comBuy Rating Affirmed for Pharming Group on Leniolisib’s Progress and Joenja’s Market ExpansionOctober 11, 2024 | markets.businessinsider.comPharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - What's Next?Pharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - Here's WhyOctober 10, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up - Should You Buy?Pharming Group (NASDAQ:PHAR) Shares Gap Up - Should You Buy?October 7, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Stock Price Down 4.8%Pharming Group (NASDAQ:PHAR) Stock Price Down 4.8%October 2, 2024 | marketbeat.comPharming Group shares hold Buy rating on UK drug nodSeptember 28, 2024 | investing.comPharming Group’s Joenja Garners Buy Rating Amid Regulatory Successes and Growth PotentialSeptember 26, 2024 | markets.businessinsider.comPharming Group (NASDAQ:PHAR) Rating Reiterated by HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $37.00 price objective on shares of Pharming Group in a research note on Thursday.September 26, 2024 | marketbeat.com Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter. Email Address This Indicator called BOTH NVDA rallies (Ad)Rarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… Click this link here. PHAR Media Mentions By Week PHAR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHAR News Sentiment▼0.410.59▲Average Medical News Sentiment PHAR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHAR Articles This Week▼92▲PHAR Articles Average Week Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PTGX News Today AMRX News Today LBPH News Today LGND News Today GERN News Today NAMS News Today IDYA News Today CNTA News Today WVE News Today AKRO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PHAR) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
